Until recently the treatment of complications of smallpox vaccination has been exclusively symptomatic. However, during the past decade specific therapeutic measures have become available. In addition to antivaccinial y-globulin, which may be of value in skin complications such as generalized vaccinia (Kempe, Berge, and England, 1956; Kempe, 1960;  Sussman and Grossman, 1965) , there now exists the possibility of using chemotherapeutic agents. One of these is methisazone (1-methylisatin 3-thiosemicarbazone) which was first used for therapeutic purposes in 1962 in a case of eczema vaccinatum with a favourable outcome (Turner, Bauer, and Nimmo-Smith, 1962 ). This compound is also effective in the prevention of smallpox in persons who have been in contact with the disease (Bauer et al., 1963) . Several reports have also appeared on the treatment of complications of smallpox vaccination with methisazone, with favourable results (Adels and Oppe, 1966; Barlow, 1962; Daly and Jackson, 1962; Hansson, Johansson, and Vahlquist, 1966) or doubtful (Connolly, Dick, and Field, 1962;  Received 20 February 1970. Flewett and Ker, 1963; White, 1963) . In a continuation of previous work on the prophylaxis of vaccination reactions with methisazone and y-globulin (Jaroszyn'ska-Weinberger and M6szaros, 1966) , the results of a study of the therapeutic value of methisazone in complications of smallpox vaccination are now presented. Materials and Methods Between June 1964 and December 1967, 50 anti-inflammatory ointment, sometimes with the addition of hydrocortisone). In addition, 19 children were given y-globulin by intramuscular injection, including 8 in the group not treated with methisazone (4-5-15 ml., equivalent to 0 -2-0-8 ml./kg.) and 11 in the treated group (3 0-7 * 5 ml., equivalent to 0 * 2 ml.fkg.). The yglobulin used was a 15% solution of Polish manufacture, prepared from the blood of revaccinated donors, which, as shown previously (Meszaros, Jaroszyn'ska-Weinberger, and KrQska, 1965) On this basis of Table II and the analysis of  Table III , it can be stated that the course of healing of accidental vaccination lesions and its completion in relation to the day of vaccination (or infection) is much nearer to the physiological duration in the group treated with methisazone. In this group 8 children received y-globulin in addition in doses of 3-6 ml. (0 -2 ml./kg.). In 5, accidental infection with vaccinia occurred in spite of the administration of y-globulin 5-10 days previously (Cases 24, 28, 33, 37, and 38) ; the remaining 3 (Cases 25, 32, and 39) received the injection on the same day as treatment with methisazone was begun, and in these children a drying up of the lesions was seen as late as 4 days after the start of the combined treatment. It, therefore, does not seem that the administration of y-globulin in a dose of 0 -2 ml./kg. played any decisive part in the prevention of accidental vaccination infection and the acceleration of the healing of the lesions in these cases.
In addition to the cases of accidental vaccination described above, 11 children with other complications of vaccination were observed; 7 with eczema vaccinatum and 4 with localized vaccinia gangrenosa. They are presented in Table IV The results of local application of methisazone were surprisingly good in all 3 cases, which included 1 case each of eczema vaccinatum (Case 45), numerous lesions of accidental vaccination on the face (Case 39), and vaccinia gangrenosa (Case 50). Flattening of the lesions was observed, and regression of the surrounding inflammatory infiltration. The results were particularly worthy of mention in Case 45 (eczema vaccinatum), in which the drug was only used locally, without oral administration; it was smeared unilaterally on an area of the shoulder covered with vaccinial lesions, the other side being left without treatment: drying up and healing of the lesions on the treated side took place considerably more rapidly and came on after 2 days of treatment. In Case 50 (vaccinia gangrenosa) methisazone was used locally after the interruption of oral treatment on account of vomiting; when the suspension was smeared on the edges of the ulcer it appeared to cause further progression of the healing process. In this child the healed lesion, around 30 days after vaccination, was covered with a scab of diameter around 10 mm., similar to that after normal vaccination; the diameter of the ulcer on the day of starting treatment was around 50 mm.
Side-effects seen during oral administration of the drug mainly consisted of vomiting; this occurred in 8 children among 21 who were given the drug by mouth; apart from this, a red coloration was noted in the urine in 2 patients, but no pathological constituents could be found on microscopical and chemical investigation. In 1 child a transient punctate exanthem appeared on the trunk; however, it was uncertain whether this was a result of treatment or a concomitant manifestation of the complication of vaccination.
Discussion
The results of treatment described concern 3 types of complications of vaccination; accidental vaccination, eczema vaccinatum, and vaccinia gangrenosa.
In accidental vaccinations, which comprised the largest group, good results were obtained from treatment with methisazone. The healing of the lesions, counting from the day of vaccination, was more rapid in the group treated with methisazone (mean 13 * 3 days) than in the group treated by other methods (mean 17 8 days), though the difference did not attain statistical significance (p> 0 2).
The course of the healing process was nearer to that of the normal reaction to vaccination; the lesions in the children treated with metbisazone healed within 6 days in most cases, whereas in the untreated group the duration of healing exceeded this period in a statistically significant number of cases (p<0 01). The course of this complication is generally mild; the lesions heal spontaneously. Kempe, 1960, 7 cases). During the course of 2-3 days of treatment with methisazone the skin lesions ceased to enlarge and began to heal. As in the reports of the above-quoted authors, our own observations showed that the use of y-globulin did not always give immediate and satisfactory results, whereas the introduction of methisazone treatment led to decisive improvement. In two very severe cases of eczema vaccinatum with generalized progressive lesions, healing was complete about 7-10 days earlier (17-21 days) in the group treated with methisazone than in the two equally severe cases in the group treated by other methods (28-31 days), though it is impossible to draw any conclusions in view of the small number of observations.
In the children with non-progressive vaccinia gangrenosa the results of treatment were more indefinite. However, apart from an equal healing time (33-36 days) of the lesions in both groups, in the children treated with methisazone a delimitation of the necrotic areas was observed, and cessation in the appearance of new lesions around the margins of the ulcer, which granulated more rapidly and became shallower. These observations find confirmation in reports in the literature on the favourable results of methisazone treatment in patients with vaccinia gangrenosa who did not react to treatment with y-globulin (Hansson et al., 1966; Kempe, 1967) .
The results of local treatment with methisazone are worthy of attention. In all 3 cases observed the results were good and consisted of rapid diminution of surrounding oedema and flattening and drying up of the lesions, which proceeded more rapidly than in the areas of skin which were not treated locally. The observations of Connolly et al. (1962) were not so encouraging. They used methisazone as a 10% ointment in 1 child and observed a toxic-allergic rash which they ascribed to the methisazone treatment; however, this was a very severe case of progressive vaccinia gangrenosa associated with antibody deficiency in which methisazone treatment was carried on for 15 days in spite of the appearance of the above-mentioned manifestations and other side-effects at the 10th day of treatment. Spiess, Kdlckell, and Schneweis (1966) , however, obtained a favourable effect with local injection in experimental animals. These results are worthy of notice in view of the fact which we have stressed that vomiting is a frequent side-effect of oral treatment wich methisazone. In our own cases we observed vomiting in 8 children among 21 treated orally; in 4 this led to the termination of the planned course of treatment. In view of the appearance of side-effects and the possibility of a toxic action, the use of short courses of methisazone seems indicated, as adhered to in our observations.
Histories of Patients Treated with
Methisazone Case 45. Eczema vaccinatum. A girl aged 2 years from a large family living in bad conditions (6 children and 2 adults in 2 rooms). History of infantile eczema treated in the dermatological clinic October-December 1966. On the day of vaccination there was infantile eczema in the stage of improvement, but still with traces of lesions on the skin. Primary vaccination 21 May 1967 without y-globulin cover. The lesion healed normally and dried into a scab. On 15 June the child scratched off the scab and transfer of the infection took place to the skin ofthe shoulders, which were affected by eczema. At the same time the child again became febrile up to 39 'C. She was admitted to hospital on 17 June. On examination the temperature was 38 'C. and the general condition was good. On the skin of the shoulders and arms there were numerous vaccinial lesions, thickly clustered, in places confluent and weeping. The skin was rough, with signs of scratching. At the site of vaccination on the left arm there was a large lesion 25 mm. in diameter, partly covered with a scab. Treatment: penicillin 600,000 units, calcium Sandoz 10%, 5 ml. injected intramuscularly on 2 successive days, promethazine. In addition methisazone was given locally from 18 June. A 20% suspension was smeared on the shoulders at the site of the lesions on one side only (left); the right side was left without treatment. Over a period of 24 hours improvement was observed on the side treated with methisazone, in that the lesions ceased weeping and began to dry up. On 19 June, 3 ml. y-globulin was given intramuscularly, and the skin of the shoulders was treated with methisazone on both sides. On 20 June the skin of the shoulders and arms on both sides was drying up simultaneously. Treatment was discontinued on 21 June, and the course lasted 3 days. Improvement continued during the next few days. On 22 June further local treatment was given with 1:1000 Rivanol solution, for the child was scratching the drying lesions from time to time. Healing was complete on 24 June. Case 46. Eczema vaccinatum. A boy aged 6 years. History of eczema, treated as an out-patient, with localization of the lesions in the popliteal and anti-cubital fossae. During a period of improvement three attempts were made to carry out smallpox vaccination, all of which gave a negative result. On 27 May 1966 the skin was without eczematous lesions, but was dry and thickened in the popliteal and antecubital fossae. Vaccination against smallpox was carried out that day; 4 days later (31 May) 3 ml. y-globulin were given when it was seen that the vaccination had been successful. On 3 June lesions resembling vaccinia appeared in the popliteal fossae, mainly on the right side, and the temperature rose to 38-39 'C. Oral promethazine was prescribed. On 7 June there was no improvement, and new vaccinial lesions had appeared below the nose and in the right nostril; around the lesions in the popliteal fossae there was an inflammatory infiltrate, engorgement of the vessels, and enlargement of the regional lymph nodes. On 7 June oral treatment with methisazone was begun, in the following doses: first day, 5 ml.; second day, 2 doses of 2 * 5 ml.; third day, 2 doses of 2 * 5 ml. The total dose was 3 g. Improvement was seen on 8 June, and on 9 June there was complete healing and drying up of the lesions, both in the popliteal fossae and the nose. On 10 June complete healing of all lesions was observed at out-patients. In this case the effect of methisazone was good in spite of the small total dose, which was all retained; the case was not one of generalized eczema vaccinatum, and the lesions were localized in distribution.
The complication arose in spite of the prophylactic administration of y-globulin 4 days after vaccination.
Case 47. Generalized eczema vaccinatum. 1 year and 6 months. Infantile eczema since the second month of life; never vaccinated against smallpox. Child's family were vaccinated against smallpox, 21 June 1965. On 26 June the child began to develop pustular lesions on the face, which became confluent and weeping, with fever up to 40 'C.; the lesions which resembled vaccinial vesicles were situated on the eczematous areas and continued to spread. On 28 June 3 ml. y-globulin were injected without effect. On 1 and 2 July severe general condition, lesions spreading, weeping, becoming confluent, particularly on the face; doughy oedema of the face and skin of the head developed. On the same day treatment with methisazone was begun, which was given by mouth 3 times a day in a dose of 0 5 g. (7 5 ml. per day). On the second day of treatment (3 July) diminution of the oedema of the skin of the face and head was noted, no new lesions appeared, though the temperature was still raised (39 'C.). On 5 July the temperature fell to 38 'C., healing of the lesions was obvious, and the scabs were beginning to become detached; there were no new lesions. However, it was necessary to discontinue methisazone treatment after 5 days as vomiting had occurred on 3 occasions. Further treatment was carried out with other agents; penicillin, erythromycin, promethazine, a further dose of y-globulin (4 5 ml.), transfusion of blood and plasma. Further complications set in which required treatment (7 July, subglottal laryngitis; 15 July, dyspepsia). By means of methisazone it was possible to arrest the further progress of the lesions at the height of their development, but it was not possible to continue with the treatment on account of vomiting. The result obtained was an improvement rather than a cure. Healing of the skin was complete by 12-14 July. The total dose of methisazone in this case amounted to 7 * 5 g.
Case 48. Generalized eczema vaccinatum. A girl aged 9 months. The patient had not hitherto been vaccinated against smallpox on account of lesions of infantile eczema on the skin. Recently the lesions had been in the phase of healing. She came in contact with vaccinia when her sister was vaccinated. About 2 weeks after contact with the vaccinated sister, the patient developed an exacerbation of the eczema on the cheeks, and on the following day there appeared a generalized eruption of vaccinial lesions with concentration in the area of the vagina and anus, the lids of both eyes (with great swelling), together with involvement of the cheeks, nose, chin, circumoral area, popliteal fossae, and groins. 3 days after the appearance of the lesions, treatment was begun with penicillin and promethazine and after 4 days with methisazone, in the following doses: 200 mg./kg. on the 1st day, and 100 mg./kg. daily for a further 6 days. The total dose of methisazone was 11 * 2 g. The effect of treatment was already noticeable on the 3rd day; the lesions became flattened and began to dry up, and the swelling of the eyelids diminished. Beginning from the 4th day the temperature fell to normal, no further lesions appeared, and the process of healing continued. On the 7th day of treatment a macular erythematous exanthem appeared, localized to the lower limbs and trunk, possibly due to the administration of the drug. Treatment with methisazone was discontinued. The eruption disappeared the next day. Healing of the lesions continued for a few more days. Recovery and healing were complete 21 days after the appearance of the vaccinial lesions.
In this case a marked therapeutic effect was obtained with methisazone and non-specific local and general treatment. y-globulin was not given.
Case 49. Vaccinia gangrenosa. A girl aged 4j years. Primary smallpox vaccination was carried out on 10 October 1966. Between 4 and 7 days after vaccination a thick black scab formed, about 20 mm. in diameter, from under which turbid fluid was coming. The temperature was 38 5-39 'C. Between 8 and 11 days after vaccination the scab underwent demarcation, disclosing a necrotic base of diameter around 30 mm., lying within a crater with punched out walls. The margins of the lesion were raised, with isolated fresh lesions of vaccinial type. The surrounding area of erythema was inconsiderable. On 21 October, 11 days after vaccination, oral treatment with methisazone was begun, and penicillin was given as well. The dose of methisazone was as follows: 1-4 g. (around 100 mg./kg.) in 1 dose, and on the following 4 days 2 * 4 g. daily (around 100 mg./ kg.). Within the first 2 days of treatment the fresh vaccinial lesions around the ulcer appeared to be healing and drying up. No new lesions appeared. On 22 October 3 ml. y-globulin were given. The lesion healed very slowly, since the cavity was deep; a necrotic scab formed and became detached 3 times during the period of hospitalization, which lasted until the 33rd day after vaccination. On the day of discharge the site of inoculation on the shoulder was covered with a fine scab about 10 mm. in diameter, which had dried level with the surface of the skin.
In this case the administration of methisazone was accompanied by cessation of the development of the lesion and appearance of new ones. This might have been due to the y-globulin which was given subsequently, but probably not in view of the low dose (3 ml.) and the weak effect of y-globulin on local reactions observed previously (Jaroszyniska-Weinberger and Meszaros, 1966) . It was necessary to discontinue methisazone treatment after 5 days on account of vomiting, and for this reason it is possible that the full therapeutic effect could not manifest itself.
Case 50. Vaccinia gangrenosa. A boy aged 4 years. Primary vaccination on 18 October 1967. After 9 days there was a fairly extensive local reaction, and eruption surrounded by satellite lesions, and later a scab underlain by fluid. The temperature rose again to 39 -2 'C. between 3 and 5 November and an abscess formed on a deep infiltrate above the site of vaccination on the left shoulder but on the postero-lateral aspect (therefore not due to inflammation of the regional lymph nodes). The abscess became open on 6 November and the contents were purulent. The patient was admitted on 7 November. On admission the temperature was normal and the general condition was good. On the left shoulder there was a necrotic area of diameter around 40-50 mm.; it was deep, with gaping margins. Above the site of vaccination and passing on to the trunk there was a firm red infiltrate, with the crater of the ulcer opening in it and discharging a sero-sanguineous fluid. The base of the necrotic lesion at the site of vaccination was unreactive with no signs of healing. Penicillin was given and methisazone in the following doses: 10 ml. on the 1st day, and 15 ml. daily on the following days (around 100 mg./kg. daily). Oral administration was continued for 6 days, and the total dose of methisazone was 17-0 g. In addition, compresses of 3% sodium bicarbonate solution were applied locally. Improvement was noted on 9 November on the second day of treatment with methisazone; while the diameter of the ulcer remained unchanged, the base and margins became clean and the base began to granulate. On 10 November the base was continuing to fill out and the diameter ofthe defect was now 40-45 mm. On 12 November there was further improvement, but on account of vomiting the oral administration of methisazone was discontinued. However, the margins of the lesion were smeared with methisazone for a further 3 
